<DOC>
	<DOCNO>NCT00006324</DOCNO>
	<brief_summary>The purpose study find whether hormonal birth control increase , decrease , change risk woman become infected HIV . Sexual intercourse men woman main way HIV transmit . About 90 percent HIV infection woman cause sexual intercourse . Also , hormonal birth control widely use . This study hop find whether hormonal birth control change risk woman become infected HIV .</brief_summary>
	<brief_title>Hormonal Birth Control Risk Acquiring HIV</brief_title>
	<detailed_description>Heterosexual intercourse primary mode HIV transmission worldwide account 90 % HIV infection woman . Hormonal contraceptive include COCs injectables among widely use contraceptive world . Understanding impact hormonal contraception HIV transmission critical unanswered public health question . Because critical nature issue woman reproductive age worldwide , methodologically sound study must undertake . It must determine hormonal contraceptive use increase risk HIV infection magnitude association , exist . This study take place Thailand , Uganda , Zimbabwe . HIV-seronegative woman continue use current birth control method ( low dose COC , DMPA injection , non-hormonal contraceptive method [ condoms , sterilization , modern contraception method ] ) duration study . They follow every 12 week minimum 15 month maximum 24 month , seroconversion . Pelvic exam , include Pap smear , do , blood sample draw , vaginal cervical specimen test sexually transmit disease ( STDs ) . Women provide free treatment STDs diagnose . They complete questionnaire sexual behavior contraceptive history ; counsel contraceptive use reduce HIV risk provide .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Inclusion Criteria Women may eligible study : Are 16 35 year age . Attend family plan maternal child health clinic Zimbabwe , Thailand , Uganda . Have use lowdose birth control pill , DMPA injection , nonhormonal birth control ( condom , sterilization , modern birth control method ) least 3 month plan continue use type birth control year . Are HIVnegative . Are sexually active . Are least 4.5 month delivery , give birth . Agree study procedure , include HIV test every 3 month , followup clinic visit , home visit fail return followup . Have home address reach followup visit . Exclusion Criteria Women eligible study : Are pregnant plan try become pregnant next year . Women become pregnant enrol trial discontinue . Are currently use lowdose birth control pills DMPA birth control use lowdose birth control pill within last 3 month , DMPA birth control within previous 6 month . Are HIVindeterminate HIVpositive . Have use IUD birth control last month . Have use nonstudy type birth control ( Norplant , NETEN , progestinonly pill ) within last 3 month . Have full hysterectomy . Have abortion miscarriage within last month . Have blood transfusion within last 3 month . Were previously currently HIV vaccine trial . Injected illegal drug within last 3 month .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Delayed-Action Preparations</keyword>
	<keyword>Risk Factors</keyword>
	<keyword>Prevalence</keyword>
	<keyword>Contraceptive Agents , Female</keyword>
	<keyword>Contraceptives , Oral , Combined</keyword>
	<keyword>Medroxyprogesterone 17-Acetate</keyword>
</DOC>